Midkine inhibits bradykinin-stimulated Ca2+ signaling and nitric oxide production in endothelial cells

Citation
Qk. Tran et al., Midkine inhibits bradykinin-stimulated Ca2+ signaling and nitric oxide production in endothelial cells, BIOC BIOP R, 276(3), 2000, pp. 830-836
Citations number
24
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
276
Issue
3
Year of publication
2000
Pages
830 - 836
Database
ISI
SICI code
0006-291X(20001005)276:3<830:MIBCSA>2.0.ZU;2-L
Abstract
Effects of the heparin-binding growth factor midkine (MK) were investigated on endothelial Ca2+ signaling and nitric oxide (NO) production. Bradykinin (10 nM) and thapsigargin (1 mu M) provoked large Ca2+ influxes under fura- 2/AM fluoroscopy. Pretreatment with human MK dose-dependently (1-500 ng/ml) inhibited the Ca2+ response to bradykinin but not that to thapsigargin. An ti-MK antibody prevented this effect. In Ca2+-free medium, MK greatly inhib ited intracellular Ca2+ store release by bradykinin and not that by thapsig argin, which effect was prevented by the antibody. Bradykinin increased NO production by 6.7-fold, which was inhibited 6, 44, 79, and 90% by MH at 1, 10, 100, and 500 ng/ml, respectively. MK did not affect thapsigargin-induce d NO production. Our data clearly indicate that MH inhibits bradykinin-indu ced Ca2+ response and NO production from endothelial cells. (C) 2000 Academ ic Press.